About Baveno Cooperation

The Baveno Cooperation is a recently formed official EASL consortium with a mission to set standards for the clinical management of patients with advanced chronic liver disease (ACLD) with a particular focus on complications of portal hypertension.

The Baveno Cooperation is based on previous Baveno international consensus conferences that were responsible for providing world-renowned evidence-based clinical guidelines for the prevention, diagnosis and management of portal hypertension that also set standards for trial design and definitions of clinical endpoints and priorities for future research. Baveno recommendations are updated every 5 years and often adopted by major international society guidelines including the EASL and AASLD. The first initiatives were coordinated by the Baveno Honorary President Prof. Dr. Roberto de Franchis who hosted a consensus conference in Baveno, Italy. The Baveno guidelines are developed through meticulous consensus processes by experts in the field of portal hypertension and have evolved from its 1st edition (Baveno I in 1992 ⁽¹⁾) in response to advancing knowledge ^(2-6). They are currently available in its 7th edition (Baveno VII 2022), each edition collecting a huge number of citations.

The Baveno Cooperation has been historically established as a part of EASL's framework. Its primary role involves not only the organization of the 5-yearly consensus conferences but also the broader objective of establishing a global, interdisciplinary research network in portal hypertension aimed at tackling significant research needs highlighted during the Baveno consensus conferences. This endeavor is and will be realized through the promotion and facilitation of interaction and collaboration among researchers, the identification of areas for partnership with the biotech and pharmaceutical sectors, and dedicated efforts to secure research funding. In order to pursue these objectives, the Baveno Cooperation has set-up three ad hoc committees, namely: the Communications Committee, the Research Committee, and the Finance Committee.

Baveno References:

de Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992;15:256-61. DOI: 10.1016/0168-8278(92)90044-p https://www.journal-of-hepatology.eu/article/0168-8278(92)90044-P/pdf
de Franchis R. Developing consensus in portal hypertension. J Hepatol. 1996 Sep;25(3):390-4 DOI: 10.1016/s0168-8278(96)80127-9 https://www.journal-of-hepatology.eu/article/S0168-8278(96)80127-9/pdf
de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52 .DOI: 10.1016/s0168-8278(00)80320-7 https://www.journal-of-hepatology.eu/article/S0168-8278(00)80320-7/fulltext
de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-76.DOI: 10.1016/j.jhep.2005.05.009 https://www.journal-of-hepatology.eu/article/S0168-8278(05)00304-1/fulltext
de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-8. DOI: 10.1016/j.jhep.2010.06.004 https://linkinghub.elsevier.com/retrieve/pii/S0168-8278(10)00564-7
de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743-52. DOI: 10.1016/j.jhep.2015.05.022 https://www.journal-of-hepatology.eu/article/S0168-8278(15)00349-9/fulltext
de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022;76:959-974. DOI: 10.1016/j.jhep.2021.12.022 https://www.journal-of-hepatology.eu/article/S0168-8278(21)02299-6/fulltext

The activities of the Baveno Cooperation are coordinated by its Executive and Steering committee that are advised by a Scientific Advisory Board. The Baveno statutes are approved by the EASL and form the basis of the operational agenda of the Baveno Cooperation.

The Baveno Executive committee is composed of 5 members:

Baveno President:
Prof. Dr. Jaime BOSCH
Baveno Chair:
Prof. Dr. Guadalupe GARCIA-TSAO
Baveno-Vice Chair:
Prof. Dr. Annalisa BERZIGOTTI
Baveno-Secretary:
Prof. Dr. Thomas REIBERGER
Baveno-Vice-Secretary:
Prof. Dr. Cristina RIPOLL

The Baveno Steering committee is composed of 8 members

Prof. Dr. Juan G. ABRALDES
Prof. Dr. Juan Carlos GARCIA-PAGAN
Prof. Dr. Jordi GRACIA
Prof. Dr. Vincenzo LA MURA
Prof. Dr. Mattias MANDORFER
Prof. Dr. Salvatore PIANO
Prof. Dr. Dominique THABUT
Prof. Dr. Emmanuel A. TSOCHATZIS

The operational agenda of the Baveno Cooperation is coordinated by 3 committees

COMMUNICATION committee

Annalisa BERZIGOTTI
Andres CARDENAS
Elton DAJTI
Jose Ignacio FORTEA
Laura TURCO

RESEARCH committee

Guadalupe GARCIA-TSAO
Cristina RIPOLL
Juan G. ABRALDES
Jordi GRACIA
Mattias MANDORFER
Dominique THABUT
Maja THIELE

FINANCE committee

Jaime BOSCH
Thomas REIBERGER
Manon ALLAIRE
Jose Luis CALLEJA
Wim LALEMAN
Arun SANYAL

Scientific Advisory Board

Roberto De FRANCHIS [Founding President]
Shiv SARIN
Gennaro D’AMICO
Dominique VALLA
Agustín ALBILLOS
Rafael BANARES
Joan GENESCA
Candid VILLANUEVA
David PATCH
Christoph BUREAU
Dhiraj TRIPATHI
Pierre-Emmanuel RAUTOU
Vijay SHAH
Jas BAJAJ
Puneeta TANDON
Maja THIELE
Wim LALEMAN
Virginia HERNANDEZ-GEA
Massimo PINZANI
Aleksander KRAG
Bogdan PROCOPET
Jonel TREBICKA
Alexander ZIPPRICH
Sven FRANCQUE
Vincenza CALVARUSO
Ben SHNEIDER
Guohong HAN
Hitoshi YOSHIJI
Susana G. RODRIGUES
Marika RUDLER
Dhiraj TRIPATHI
Pierre-Emmanuel RAUTOU
Vijay SHAH
Jas BAJAJ
Puneeta TANDON
Maja THIELE
Wim LALEMAN
Virginia HERNANDEZ-GEA
Massimo PINZANI
Aleksander KRAG